Skip to content
Screener

CVRx, Inc. CVRX EPS (Diluted)

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.53-47.5%
Boston Scientific logo
Boston ScientificBSX
$0.61+15.1%
Medtronic logo
MedtronicMDT
$1.14+40.7%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$0.18+30.8%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$0.39-8.3%
LivaNova logo
LivaNovaLIVN
$1.93+286%

Other financials

Income statement

See full
Revenue$15.7M+15.6%
Gross profit$13.7M+19.9%
Operating income-$13.0M+9.4%
Net income-$14.0M+4.7%

Balance sheet

See full
Cash & equivalents$64.6M-32.0%
Total debt$59.4M+17.5%
Total equity$20.0M-65.6%
Total assets$92.3M-22.8%

Cash flow

See full
Operating cash flow-$8.8M-11.2%
CapEx$112.0K+8.7%
Free cash flow-$8.9M-11.2%

Valuation

See full
Market cap$80.46M-54.5%
Enterprise value$75.26M-43.1%
P/S1.3×-1.9×

Profitability

See full
Gross margin86.9%+3.4pp
Operating margin-79.5%-10.4pp
Net margin-84.9%-8.5pp
FCF margin-67.1%-4.4pp

Returns & leverage

See full
Return on equity-133.4%+107pp
Debt / equity+2.1×
Current ratio-3.9×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: CVRx, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054336
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other income, net5601,1101,1532,233
Loss before income taxes(14,041)(14,739)(27,160)(28,510)
Benefit (provision) for income taxes(3)3(4)8
Net loss(14,044)(14,736)(27,164)(28,502)
Cumulative translation adjustment33
Comprehensive loss$(14,044)$(14,733)$(27,164)$(28,499)
Net loss per share, basic and diluted$(0.53)$(0.57)$(1.03)$(1.10)
Weighted-average common shares used to compute net loss per share, basic and diluted26,515,44226,071,31626,435,95825,974,229

Item 1. Financial Statements

FAQ

What is CVRx, Inc.'s EPS (diluted)?
CVRx, Inc. (CVRX) reported EPS (diluted) of -$0.53 in Q2 2026.
How has CVRx, Inc.'s EPS (diluted) changed year-over-year?
CVRx, Inc.'s EPS (diluted) increased by 7.0% year-over-year, from -$0.57 to -$0.53.
What is the long-term trend for CVRx, Inc.'s EPS (diluted)?
Over 3 years (2022 to 2025), CVRx, Inc.'s EPS (diluted) has grown at a 0.3% compound annual growth rate (CAGR), from -$2.02 to -$2.04.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about CVRx, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude